Life Sciences IPOs Take a Breather December 02, 2013 | Press Release
Booming IPO Market Improving M&A Terms for Private Biotechs November 01, 2013 | Press Release
ADMA Biologics, Inc. Announces Pricing October 18, 2013 | Press ReleaseSee all News
Stephen A. HurlyCEO, Burrill Securities
Stephen A. Hurly joined Burrill Securities as its CEO in June 2011. He brings an expertise in assisting public and private firms with strategic transactions, difficult financings, product licensing, joint ventures and restructurings. He has experience at both bulge bracket firms as well as specialized boutiques. Through extensive industry relationships and global transaction experience in China, Japan, Australia, the European Union, and North America, Mr. Hurly and his team provide tailored solutions and insight to assist clients in reaching their strategic goals.
Mr. Hurly has previously worked at Hambrecht & Quist in San Francisco, and UBS in New York City. He is an expert in strategic transactions and difficult public and private capital raising. He has completed more than 100 transactions with an aggregate value of more than $10 billion and more than $400 million in capital raised. He has an M.B.A. from the University of Chicago and a B.S. in Engineering from Swarthmore College.